Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Monocrotaline-induced pulmonary arterial hypertension: Time-course of injury and comparative evaluation of macitentan and Y-27632, a Rho kinase inhibitor.
Novelli D, Fumagalli F, Staszewsky L, Ristagno G, Olivari D, Masson S, De Giorgio D, Ceriani S, Affatato R, De Logu F, Nassini R, Milioli M, Facchinetti F, Cantoni S, Trevisani M, Letizia T, Russo I, Salio M, Latini R. Novelli D, et al. Among authors: de giorgio d, de logu f. Eur J Pharmacol. 2019 Dec 15;865:172777. doi: 10.1016/j.ejphar.2019.172777. Epub 2019 Nov 4. Eur J Pharmacol. 2019. PMID: 31697933
The TRPA1 channel mediates the analgesic action of dipyrone and pyrazolone derivatives.
Nassini R, Fusi C, Materazzi S, Coppi E, Tuccinardi T, Marone IM, De Logu F, Preti D, Tonello R, Chiarugi A, Patacchini R, Geppetti P, Benemei S. Nassini R, et al. Among authors: de logu f. Br J Pharmacol. 2015 Jul;172(13):3397-411. doi: 10.1111/bph.13129. Epub 2015 Apr 24. Br J Pharmacol. 2015. PMID: 25765567 Free PMC article.
Thrombophilic status may predict prognosis in patients with metastatic BRAFV600-mutated melanoma who are receiving BRAF inhibitors.
Falanga A, Marchetti M, Massi D, Merelli B, Verzeroli C, Russo L, Rulli E, Tondini C, Legramandi L, Nassini R, Scatena C, De Logu F, Cattaneo L, Mandalà M. Falanga A, et al. Among authors: de logu f. J Am Acad Dermatol. 2016 Jun;74(6):1254-1256.e4. doi: 10.1016/j.jaad.2015.11.006. J Am Acad Dermatol. 2016. PMID: 27185428 No abstract available.
Topical treatment with a transient receptor potential ankyrin 1 (TRPA1) antagonist reduced nociception and inflammation in a thermal lesion model in rats.
de David Antoniazzi CT, De Prá SD, Ferro PR, Silva MA, Adamante G, de Almeida AS, Camponogara C, da Silva CR, de Bem Silveira G, Silveira PCL, Oliveira SM, Rigo FK, De Logu F, Nassini R, Trevisan G. de David Antoniazzi CT, et al. Among authors: de almeida as, de bem silveira g, de logu f, de pra sd. Eur J Pharm Sci. 2018 Dec 1;125:28-38. doi: 10.1016/j.ejps.2018.09.012. Epub 2018 Sep 17. Eur J Pharm Sci. 2018. PMID: 30236550
71 results